Kindstar Globalgene Technology, Inc. (HKG:9960)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.220
+0.030 (2.52%)
Apr 20, 2026, 4:08 PM HKT

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Hematology Testing
563.13M585.11M590.31M525.80M535.27M
Hematology Testing Growth
-3.76%-0.88%12.27%-1.77%14.05%
Neurology Testing
95.05M95.35M96.60M95.35M89.85M
Neurology Testing Growth
-0.31%-1.30%1.31%6.12%18.16%
Maternity-Related Testing
50.24M53.88M55.42M49.96M52.25M
Maternity-Related Testing Growth
-6.75%-2.77%10.92%-4.38%0.25%
Genetic Disease and Rare Diseases
40.94M44.75M46.72M42.78M43.50M
Genetic Disease and Rare Diseases Growth
-8.50%-4.21%9.20%-1.65%20.23%
Infectious Diseases
35.44M39.43M49.00M47.69M51.97M
Infectious Diseases Growth
-10.12%-19.53%2.74%-8.23%3.03%
Oncology Testing
44.80M21.72M32.06M17.87M8.62M
Oncology Testing Growth
106.22%-32.25%79.41%107.45%13.40%
Routine Testing
41.28M42.39M57.47M57.44M67.67M
Routine Testing Growth
-2.64%-26.24%0.06%-15.12%0.20%
Scientific research services and CRO
59.57M44.66M26.39M7.94M-
Scientific research services and CRO Growth
33.40%69.20%232.53%--
Others
3.12M277.00K13.29M5.14M19.46M
Others Growth
1024.55%-97.91%158.66%-73.60%36.10%
COVID-19 Related Testing
---536.63M62.10M
COVID-19 Related Testing Growth
---764.07%-47.30%
Total
933.57M927.57M967.26M1.39B930.67M
Total Growth
0.65%-4.10%-30.24%48.99%4.41%

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Mainland China
933.57M927.57M967.26M1.39B930.67M
Mainland China Growth
0.65%-4.10%-30.24%48.99%4.41%
Total
933.57M927.57M967.26M1.39B930.67M
Total Growth
0.65%-4.10%-30.24%48.99%4.41%
Source: S&P Global Market Intelligence.